Paras Vakharia, MD, PHARMD
NPI 1447756473 · Dermatology Physician · Chicago, IL
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1447756473
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PHARMD
- Sex
- Male
- Sole proprietor
- No
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
8 yrs in NPPES registry
- Profile completeness25% of score
83% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
2,233 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 663 | $7 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 355 | $132 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 225 | $94 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 195 | $55 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 124 | $17 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 31 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 265 | 160 |
| Ketoconazole | 143 | 78 |
| Clobetasol Propionate | 117 | 51 |
| Dupilumabbrand: Dupixent Pen | 99 | 14 |
| Mupirocin | 75 | 39 |
| Mometasone Furoate | 72 | 41 |
| Doxycycline Monohydrate | 67 | 36 |
| Minoxidil |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$284 across 8 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 3722 Harlem Ave Ste Ll34Riverside, IL 60546-2320Phone: (708) 783-6566Fax: (708) 783-6567
- 6000 Harry Hines BoulevardDallas, TX 75390-2320Phone: (214) 648-3422
Registry dates
- Enumerated
- 2018-03-30
- Last updated
- 2022-08-16
- Certified
- 2022-06-26
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.